Celcuity Inc. CELC 深 沪
等待开盘 06-19 09:30:00 美东时间
87.76
-0.290
-0.33%
华盛通- 最 高89.40
- 今 开88.17
- 成交量 210.35万股
- 最 低 82.5536
- 昨 收 88.05
- 总市值 42.80亿
- 52周最高 151.02
- 市盈率 静 --
- 换手率 4.31%
- 52周最低 12.48
- 委 比 15.77%
- 总股本 4876.63万
- 历史最高 151.02
- 量 比 1.64
- 振 幅 7.78%
- 历史最低 4.03
- 每 手 1
- 风险率 36.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股周涨跌榜 | 维多利亚的秘密周涨超35%！财报及业绩指引均超预期；获黄仁勋“喊单”，迈威尔科技周涨超28%
维多利亚的秘密周涨超35%！财报及业绩指引均超预期；迈威尔科技周涨超28%，此前获黄仁勋“喊单”！称其有望晋级万亿美元市值；传奇生物周涨超20%，CAR-T细胞疗法实验数据引爆市场>>
06-06 11:25
Reported Earlier, Celcuity Prices Upsized $500M Convertible Notes Offering (Up From Prior $400M)
Celcuity Inc. (NASDAQ:CELC) ("Celcuity" or the "Company"), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced
06-04 16:14
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
Craig-Hallum Maintains Buy on Celcuity, Lowers Price Target to $171
Craig-Hallum analyst Alexander Nowak maintains Celcuity (NASDAQ:CELC) with a Buy and lowers the price target from $189 to $171.
06-04 01:37
BUZZ-Celcuity drops further after announcing $400 mln convertible offering
BUZZ-Celcuity drops further after announcing $400 mln convertible offering ** Biotech firm Celcuity CELC.O shares down 2.6% at $89.05 early Weds as it seeks capital raise ** Minneapolis, Minnesota-based firm early Weds announces public offering of $400 mln convertible bonds (CBs) due 2032 ** CELC sh
06-03 22:33
Celcuity announces $400M convertible notes offering
Celcuity (NASDAQ: CELC) on Wednesday said that it plans to offer $400 million of convertible senior notes due 2032 in an underwritten public offering. The clinical-stage biotechnology company said it ...
06-03 19:41
What's Going On With Celcuity Stock On Tuesday?
Celcuity reported Phase 3 data showing gedatolisib improved progression-free survival in PIK3CA-mutated breast cancer.
06-03 01:37
Celcuity To Host Conference Call And Live Webcast To Review Results From PIK3CA Mutant Cohort Of Phase 3 VIKTORIA-1 Clinical Trial On June 2
Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced it will host a conference call
06-01 20:32
Celcuity amends 8-K to provide full text of amended Item 5.02 disclosures
Celcuity amends 8-K to provide full text of amended Item 5.02 disclosures Celcuity filed an amended Form 8-K to update and complete its disclosure on the Feb. 11, 2026 board change. The amendment reflects the board expansion to eight directors, the appointment of Charles (Chip) R. Romp as an indepen
05-20 19:31
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
